Joseph Keegan

Dr. Joseph Keegan joined Arrayjet in 2017 and currently serves as a director and advisor to Interpace Diagnostics (Nasdaq: IDXG), as well as many privately-held life science companies, including as Chair of Labcyte, Inc., and also as a director at Carterra and Nanomedical Diagnostics. From 2007 until its sale to Pall Corporation in 2012, Dr. Keegan served as President and Chief Executive Officer of ForteBio, Inc. Dr. Keegan joined ForteBio from Molecular Devices Corporation, where he served as President and Chief Executive Officer from 1998 to 2007. Before Molecular Devices, Dr. Keegan held leadership positions at Becton Dickinson, Leica, Inc., and GE Medical Systems. He has also served on numerous public and private company boards of life science tools companies.

Dr. Keegan holds a Ph.D. in Physical Chemistry from Stanford University. Among other attributes, skills and qualifications, the Board believes Dr. Keegan is qualified to serve as a Director of the Company because of his deep knowledge of the industry and customers, as well as his extensive executive management experience and prior service on other private and public company boards.